How does dulaglutide behave on a C18 column compared to retatrutide?

Setup, so nobody has to ask: dulaglutide · a C18 column · retatrutide.

I suspect the honest answer is that it depends, in which case I would like to know on what.

Assume I can obtain either option without difficulty, so availability is not the deciding factor.

What is the actual trade-off, and does it matter at the scale I am working at?

Start by understanding what the detector is measuring and what that means about how the molecule needs to be prepared and handled before injection.

Reverse-phase stationary phases use C18 or C8 chains bonded to silica, and the pore size of the silica matters more for a peptide of this chain length than the ligand length does.

Formic acid is the compromise when you need the mass spectrometer on the same run, but the peak shape penalty is real and easily a tenth of a per cent on purity.

The limitation is that co-elution is invisible — if two species happen to have the same retention time, they will report as a single peak at their combined area.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

The most important parameter is the one that is almost never specified: the gradient slope during the region where your main peak elutes.

System suitability checks on replicate injections of a known standard establish whether the method was in control — if the peak area varies by more than two per cent between replicates, something is wrong.

Mechanically, detector linearity is why a heavily loaded peak can give false purity by compressing the main peak height while leaving impurity shoulders unchanged.

The selectivity of a reverse-phase separation depends on the hydrophobicity of the side-chain profile, which is why two peptides can co-elute even if they differ by a residue.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.

Peak shape carries as much information as peak area does, and a badly tailing peak or a shouldered peak is telling you something about the sample or the column that matters.

Acetonitrile is the organic modifier of choice because it has a good UV cutoff, a reasonable viscosity and a refractive index that minimises baseline noise.

Inter-laboratory studies using identical methods on identical material show precision well within half a per cent when the method is locked down, pointing to method variability as the primary source of disagreement.

Ask for the chromatogram and the system suitability data, not just the number.

edited 29 Oct 2025 by tri_gly_ala — expanded the table to cover the lower concentration

To be exact about it, gradient design is usually described as though it is a minor technical detail rather than the primary determinant of what the method measures.

Wider-pore phases — 300 Angstrom rather than 100 Angstrom — have faster mass transfer and narrower peaks for peptides above three kilodaltons, which is almost every peptide you will see.

Peptide separation by reverse-phase high-performance liquid chromatography is described in the general chapters of the United States Pharmacopeia, European Pharmacopeia and Japanese Pharmacopeia, and the methods converge on essentially the same principles.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.